FDA establishment 3009876430, Jadcherla, Mahabubnagar District, India. Part of Shilpa Medicare's FDA records. Every inspection FDA has posted for the site, with its outcome and cited regulations and its recalls since 2016.
FY2018 to FY2027 to date; 1 classified OAI
A hatched bar is a year that is not over, so its count covers only part of the year.
Inspections citing each reference
| Feb 25, 2020 | Drugs · Drug Quality Assurance | None posted | Official Action Indicated (OAI) |
| Sep 6, 2019 | Drugs · Drug Quality Assurance | 2 cited references
| Voluntary Action Indicated (VAI) |
| Nov 30, 2017 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| Jul 28, 2017 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Jul 26, 2016 | Drugs · Drug Quality Assurance | None posted | No Action Indicated (NAI) |
| Aug 26, 2015 | Drugs · Drug Quality Assurance | None posted | Voluntary Action Indicated (VAI) |
| PEMRYDI RTU (pemetrexed injection), 100 mg/10 mL (10 mg/mL), Single-dose vial, Rx only, Manufactured by…Drug · D-0764-2026 · 2 products | Class II | Jul 29, 2026 |
| Busulfan Injection 60 mg/10 mL (6 mg/mL), For Intravenous Infusion Only, Must be diluted before use, Single…Drug · D-0121-2021 · 6 products | Class II | Dec 8, 2020 |
An FEI (FDA Establishment Identifier) names one physical site. Inspections, outcomes and citations come from FDA's Data Dashboard; FDA posts citations only for some inspections. Recalls come from FDA's enforcement reports (iRES), one row per recall even when it covers many lots. A contract site can make products for many companies, so the company shown is the one FDA lists as the site's firm. Form 483 observations are read by Arca from the 483s FDA posts in its FOIA reading room, most of them scans: the first sentence of each observation, with redactions as FDA made them. FDA posts 483s for a minority of inspections. FDA Data Dashboard, warning letters and enforcement reports